These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5462615)

  • 1. [Study on the growth hormone secretion in diabetic retinopathy. II. Growth hormone secretion in relation to the prognosis of retinopathy in diabetes].
    Takeo K
    Nippon Ganka Gakkai Zasshi; 1970 Mar; 74(3):247-59. PubMed ID: 5462615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the growth hormone secretion in diabetic retinopathy. I. Growth hormone in relation to diabetic and non-diabetic retinopathy].
    Takeo K
    Nippon Ganka Gakkai Zasshi; 1969 Feb; 73(2):153-71. PubMed ID: 5815548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetic retinopathy and growth hormone secretion in 39 non insulin-dependant diabetic patients].
    Hautecouverture M; Monchi A; Tchobroutsky G; Assan R; Slama G; Derot M
    Nouv Presse Med; 1973 Jul; 2(27):1817-22. PubMed ID: 4719844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the growth hormone secretion in diabetic retinopathy. 3. Alteration of serum insulin secretion in relation to diabetic retinopathy and growth hormone].
    Takeo K
    Nippon Ganka Gakkai Zasshi; 1971 Jan; 75():543-54. PubMed ID: 5103207
    [No Abstract]   [Full Text] [Related]  

  • 5. Secretion of growth hormone in the insulin test, and the development of diabetic microangiopathy.
    Sieradzki J
    Pol Med Sci Hist Bull (1973); 1976; 15(2):191-6. PubMed ID: 959044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Growth hormone secretion in insulin test and the development of diabetic microangiopathy].
    Sieradzki J
    Pol Arch Med Wewn; 1975 Jun; 53(6):587-95. PubMed ID: 1138249
    [No Abstract]   [Full Text] [Related]  

  • 7. [Growth hormone in developmental diabetic retinopathy].
    Grange JD; Borson-Chazot F; Adad B; Cohen R; Sassolas G; Berthezene F
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):699-700, 703-4. PubMed ID: 2590989
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relation of the atherosclerosis index and fundus oculi findings in type II diabetics].
    Latinović S; Kristiforović-Ilić M; Dimoski N; Vajagić L
    Med Pregl; 1985; 38(1-2):27-31. PubMed ID: 4033551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Frequency, severity and forms of manifestation of diabetic retinopathy in relation to the status of compensation for disordered metabolism in diabetes mellitus].
    Lekishvili VP; Chkoniia EA; Bogatyreva ShI; Sulkhanishvili IZ
    Probl Endokrinol (Mosk); 1974; 20(3):20-3. PubMed ID: 4281480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of the plasma growth hormone level (HGH) on the development of diabetic retinopathy].
    Sévin R
    Bull Mem Soc Fr Ophtalmol; 1972; 85(0):213-20. PubMed ID: 4671781
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood fibrinolytic activity and fibrinogen concentration in diabetic retinopathy].
    Takeuchi Y; Fukuda M; Takeo K; Tabuchi S; Nishijo S
    Nippon Ganka Gakkai Zasshi; 1970 Feb; 74(2):151-67. PubMed ID: 5462607
    [No Abstract]   [Full Text] [Related]  

  • 12. Using a model of the colour content in retinal fundus images to screen for sight threatening diabetic retinopathy.
    Ege BM; Bek T; Larsen OV; Hejlesen OK
    Stud Health Technol Inform; 2002; 90():18-23. PubMed ID: 15460654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of pituitary deficiency by hypoglycemia-induced growth hormone secretion in hypophysectomized diabetics].
    Teuscher A; Escher F; Zahnd G
    Schweiz Med Wochenschr; 1969 Jul; 99(31):1110-4. PubMed ID: 5406976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on the pathogenesis of diabetic retinopathy--observation on serum growth hormone].
    Zhu ZR
    Zhonghua Yan Ke Za Zhi; 1984 Mar; 20(2):71-3. PubMed ID: 6435967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Growth hormone and diabetic retinopathy (author's transl)].
    Freyler H; Klemen U; Egerer I; Waldhäusl W; Dudczak R
    Klin Monbl Augenheilkd; 1978 Mar; 172(3):343-9. PubMed ID: 633768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possible role of the antioxidant system of the vitreous body in delaying the development of diabetic retinopathy].
    Alieva Za; Gadzhiev RV; Sultanov MIu
    Oftalmol Zh; 1985; (3):142-5. PubMed ID: 4011094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Somatotropic hormone, diabetes and diabetic angiopathy].
    Dobrev DG
    Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of atromide-S in the treatment of diabetic retinopathy].
    Kliachko VR; Tirkina TN; Aleksandrova LM; Mazovetskiĭ AG
    Sov Med; 1973 Dec; 36(12):59-61. PubMed ID: 4779364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on diabetic retinopathy. IV. Diabetic retinopathy by ERG and fluorescein fundus photography].
    Katsuse T
    Nippon Ganka Gakkai Zasshi; 1967 Jan; 71(1):1-14. PubMed ID: 6068736
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of diabetic lesions of the fundus oculi depending on the clinical features of diabetes mellitus].
    Danilishina VS; Vikaliuk IuF; Krapivina VA
    Oftalmol Zh; 1982; 37(8):500-2. PubMed ID: 7162747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.